---
title: "Tiziana Life Sciences regains compliance"
url: "https://aibio.space/news/tiziana-life-sciences-regains-compliance-nasdaq-minimum-bid-price-rule/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2025-03-14"
section: "Listings"
tickers: "NASDAQ:TLSA"
source: "https://www.sec.gov/Archives/edgar/data/1723069/000101376225000330/ea023443701ex99-1_tiziana.htm"
summary: "The requirement was met on March 12, 2025 after a notice dated January 29, 2025. Nasdaq considers the matter closed."
---

By the aibio.space news desk.

Sources

- [Tiziana Life Sciences Ltd 6-K (2025-03-14)](https://www.sec.gov/Archives/edgar/data/1723069/000101376225000330/ea023443701ex99-1_tiziana.htm)

[TLSA](https://aibio.space/companies/tiziana-life-sciences/)

2025-03-14

# Tiziana Life Sciences regains compliance with Nasdaq minimum bid price rule

Tickers [TLSA](https://aibio.space/companies/tiziana-life-sciences/)

The requirement was met on March 12, 2025 after a notice dated January 29, 2025. Nasdaq considers the matter closed.

## Key facts

- **Company**: Tiziana Life Sciences Ltd (NASDAQ: TLSA)

- **News type**: Listings

- **Primary source**: [Tiziana Life Sciences Ltd 6-K (2025-03-14)](https://www.sec.gov/Archives/edgar/data/1723069/000101376225000330/ea023443701ex99-1_tiziana.htm)

*The Capitol dome seen from below. Photo: U.S. Department of Homeland Security (Source), CC0, via rawpixel. The picture shows the field, not the companies named.*

Tiziana Life Sciences, Ltd. (Nasdaq: [TLSA](https://aibio.space/companies/tiziana-life-sciences/)) announced on March 14, 2025 that it received a notification from the Nasdaq Listing Qualifications Department saying it has regained compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

Nasdaq had notified Tiziana on January 29, 2025 that it was not in compliance with Rule 5550(a)(2), the minimum bid price rule. Its common stock had failed to meet a closing bid price of $1.00 or more for 30 consecutive business days.

To regain compliance, the company was required to maintain a minimum closing bid price of $1.00 or more for at least ten consecutive trading days. The company said that was met on March 12, 2025. It said the matter is now closed.

Tiziana said its securities will continue to be listed and traded on The Nasdaq Stock Market.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

TLSA

Tiziana Life Sciences Ltd

NASDAQ · Bermuda

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/tiziana-life-sciences-regains-compliance-nasdaq-minimum-bid-price-rule/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Tiziana Life Sciences regains compliance", 2025-03-14, https://aibio.space/news/tiziana-life-sciences-regains-compliance-nasdaq-minimum-bid-price-rule/